Veterinary World


ISSN (Online): 2231-0916


 Editorial board

 Instructions for authors

 Reviewer guideline

 Open access policy




Open Access

Copyright: The authors. This article is an open access article licensed under the terms of the Creative Commons Attribution License ( which permits unrestricted use, distribution and reproduction in any medium, provided the work is properly cited.

Research (Published online: 02-01-2014)

1. Binding of VEGF-A to canine cancer cells with preferential expression of VEGFR1 - Antonella Borgatti, Megan Duckett, Charles Spangler and Jaime F. Modiano
Veterinary World, 7(1): 1-6


doi: 10.14202/vetworld.2014.1-6


1. Sitohi, B., Nagy, J.A. and Dvorak, H.F. (2012) Anti-VEGF / VEGFR therapy for cancer: reassessing the target. Cancer Res., 72(8):15, 1909-1914.
2. Restucci, B., Paparella, S., Maiolino, P. and De Vico, G. (2002) Expression of vascular endothelial growth factor in canine mammary tumors. Vet. Pathol., 39:488-493.
3. Wergin, M.C. and Kaser-Hotz. (2004) Plasma vascular endothelial growth factor (VEGF) measured in 70 dogs with spontaneously occurring tumors. In Vivo, 18:15-20.
4. Tamburini, B.A, Trapp, S., Phang, T.L., Schappa, J.T., Hunter, L.E. and Modiano, J.F. (2009) Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed. PLoS One, 4(5):e5549.
PMid:19461996 PMCid:PMC2680013
5. Yonemaru, K., Sakai, H., Yanai, T. and Masegi, T. (2006) Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (FLT-1, FLK-1, and FLG-1) in canine vascular tumors. Vet. Pathol., 43: 971- 980.
6. Koch, S. and Claesson-Welsh, L. (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Sprinng Harb Perspect Med., 2:a006502.
7. Kerber, M., Reiss, Y., Wickersheim, A., Jugold, M., Kiessling, F., Heil, M., Tchaikovski, V., Walternberger, J., Shibuya, M., Plate, K.H. and Machein, M.R. (2008). Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res., 68:7342-7351.
8. Murakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y. and Shibuya, M. (2006) Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytess/macrophages. Blood, 108:(1849- 1856).
9. Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., Ferrara, N., Fyfe, G., Rogers, B., Ross, R. and Kabbinavar, F. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Eng. J. Med., 350:2335-2342.
10. Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E.A., Shenkier, T., Cella, D. and Davidson, N.E. (2007) Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N. Engl. J. Med., 357:2666- 2676.
11. Jain, R.K., Duda, D.G., Clark, J.W. and Loeffler, J.S. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat. Clin. Pract. Oncol., 3:24-40.
12. Oh, S., Stish, B.J., Sachdev, D., Chen, H., Dudek, A.Z. and Vallera, D.A. (2009) A novel reduced immunogenicity bispecific ligand targeted toxin simultaneously recognizing human epidermal growth factor and interleukin-4 receptors in a mouse model of metastatic breast carcinoma. Clin. Cancer Res., 15(19): 6137-6147.
PMid:19789305 PMCid:PMC2756320
13. Spangler, C.W., Starkey, J.R., Rebane, A., Drobizhev, M., Meng, F. and Gong, A. (2008) Synthesis, characterization and two-photon PDT efficacy studies of triads incorporating tumor targeting and imaging components. Proc. Soc. Photo. Opt. Instrum., Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVII, 68450S; doi:10.1117/12.763472.
14. Hamada, Y., Gonda, K., Takeda, M., Sato, A., Watanabe, M., Yambe, T., Satomi, S. and Ohuchi, N. (2011) In vivo imaging of the molecular distribution of the VEGF receptor during angiogenesis in a mouse model of ischemia. Blood 118(13).
15. Ritt, M.G., Wojcieszyn, J., Smith, R., Mayor, J., Barton, C.L. and Modiano, J.F. (2000) Sustained nuclear localization of p21/Waf-1 upon growth arrest induced by contact inhibition. Cancer Lett., 158, 73-84.
16. Fosmire, S.P., Dickerson, E.B., Scott, A.M., Bianco, S.R., Pettengill, M.J., Meylemans, H., Padilla, M., Frazer-Abel, A.A., Akhtar, N., Getzy, D.M., Wojcieszyn, J., Breen, M., Helfand, S.C. and Modiano, J.F. (2004) Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab. Invest., 84(5): 562-72.
17. Kasza, L. (1964) Establishment and characterization of canine thyroid adenocarcinoma and canine melanoma cell lines. Am. J. Vet. Res., 25:1178-85.
18. Scott, M.C., Sarver, A.L., Gavin, K.J., Thayanithy, V., Getzy, D.M., Newman, R.A., Cutter, G.R., Lindblad-Toh, K., Kisseberth, W.C., Hunter, L.E., Subramanian, S., Breen, M. and Modiano, J.F. (2011) Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach. Bone, 49, 356-367.
PMid:21621658 PMCid:PMC3143255
19. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
20. Schappa, J.T., Frantz, A.M., Dickerson, E.B., Vallera, D.A. and Modiano, J.F. (2013) Hemangiosarcoma and its cancer stem cell sub-population are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors. Int. J. Cancer, 133, 1936-44.
21. Pastan, I., Chaudhary, V. and FitzGerald, D.J. (1992) Recombinant toxins as novel therapeutic agents. Annu. Rev. Biochem., 61:331-54.
22. Waldron, N., Seunguk, Oh. and Vallera, D. (2012) Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma. Oral Oncol., 48 (12):1202-1207.
PMid:22818892 PMCid:PMC3480964
23. Troy, G.C., Huckle, W.R., Rossmeisl, J.H., Panciera, D., Lanz, O., Robertson, J.L. and Ward, D.L. (2006) Endostatin and Vascular Endothelial Growth Factor Concentrations in Healthy Dogs, Dogs with Selected Neoplasia, and Dogs with Nonneoplastic Diseases. J. Vet. Intern. Med., 20:144-150.
24. Clifford, C.A., Hughes, D., Beal, M.W., Mackin, A.J., Henry, C.J., Shofer, F.S. and Sorenmo, K.U. (2001) Plasma vascular endothelial growth factor concentrations in healthy dogs and dogs with hemangiosarcoma; J. Vet. Intern. Med., 15(2):131- 5.
25. Paoloni, M. and Khanna, C. (2008) Translation of new cancer treatments from pet dogs to humans. Nature Reviews, 8:147-156.